Study explores novel therapeutic treatment for glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is less than 10%.

Two major challenges hinder effective GBM treatment:

Continue Reading


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *